US BANCORP \DE\ - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$525,649
-29.3%
12,743
-4.3%
0.00%0.0%
Q2 2023$743,230
+137.5%
13,310
+137.3%
0.00%0.0%
Q1 2023$312,926
+75.9%
5,609
+14.9%
0.00%
Q4 2022$177,936
-52.6%
4,883
-62.9%
0.00%
-100.0%
Q3 2022$375,000
-42.9%
13,172
-9.2%
0.00%0.0%
Q2 2022$657,000
-11.1%
14,502
+49.3%
0.00%0.0%
Q1 2022$739,000
-28.7%
9,711
+39.6%
0.00%
-50.0%
Q4 2021$1,037,000
+26.3%
6,958
+23.4%
0.00%0.0%
Q3 2021$821,000
-20.1%
5,640
+7.6%
0.00%0.0%
Q2 2021$1,027,000
+23.6%
5,243
+14.2%
0.00%0.0%
Q1 2021$831,000
+2867.9%
4,591
+2195.5%
0.00%
Q4 2020$28,000
+12.0%
2000.0%0.00%
Q3 2020$25,000
+38.9%
2000.0%0.00%
Q2 2020$18,000
+50.0%
2000.0%0.00%
Q1 2020$12,000
-20.0%
2000.0%0.00%
Q4 2019$15,0002000.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders